Associated Papers
Recent Advances and Future Directions in Alzheimer's Disease Genetic Research.
Stancheva M et al.
International Journal of Molecular Sciences, 2025
CRISPR/Cas9-mediated knock-in cells of the late-onset Alzheimer's disease-risk variant, SHARPIN G186R, reveal reduced NF-κB pathway and accelerated Aβ secretion.
Asanomi Y et al.
Journal of Human Genetics, 2024
Genetics of Alzheimer's disease: an East Asian perspective.
Miyashita A et al.
Journal of Human Genetics, 2023
Involvement of heterologous ubiquitination including linear ubiquitination in Alzheimer's disease and amyotrophic lateral sclerosis.
Sato Y et al.
Frontiers in Molecular Biosciences, 2023
Intervention of next-generation sequencing in diagnosis of Alzheimer's disease: challenges and future prospects.
Chandy T
Dementia & Neuropsychologia, 2023
SHARPIN: Role in Finding NEMO and in Amyloid-Beta Clearance and Degradation (ABCD) Pathway in Alzheimer's Disease?
Krishnan D et al.
Cellular and Molecular Neurobiology, 2022
Linear ubiquitination in immune and neurodegenerative diseases, and beyond.
Tokunaga F et al.
Biochemical Society Transactions, 2022
A functional variant of SHARPIN confers increased risk of late-onset Alzheimer's disease.
Asanomi Y et al.
Journal of Human Genetics, 2022
A missense variant in SHARPIN mediates Alzheimer's disease-specific brain damages.
Park JY et al.
Translational Psychiatry, 2021
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.
de Rojas I et al.
Nature Communications, 2021
Met1-linked ubiquitin signalling in health and disease: inflammation, immunity, cancer, and beyond.
Jahan AS et al.
Cell Death and Differentiation, 2021
A rare functional variant of SHARPIN attenuates the inflammatory response and associates with increased risk of late-onset Alzheimer's disease.
Asanomi Y et al.
Molecular Medicine (cambridge, Mass.), 2019
Select a paper to view details